<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941019-2-00076</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> November 18, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4703 -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=1 -->  <RINDOCK>[Docket No. 94N&hyph;0369]</RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 -->  <DOCTITLE>King Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 27 Abbreviated New Drug Applications</DOCTITLE> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Food and Drug Administration, HHS. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Notice. <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> The Food and Drug Administration (FDA) is withdrawing approval of 27 abbreviated new drug applications (ANDA's). The holders of the ANDA's notified the agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> EFFECTIVE DATE:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> November 18, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </DATE> <FURTHER> <!-- PJG ITAG l=10 g=1 f=2 --> FOR FURTHER INFORMATION CONTACT:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> Lola E. Batson, Center for Drug Evaluation and Research (HFD&hyph;360), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1038. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline --> </FURTHER> <SUPPLEM> <!-- PJG ITAG l=10 g=1 f=2 --> SUPPLEMENTARY INFORMATION:  <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 --> The holders of the ANDA's listed in the table in this document have informed FDA that these drug products are no longer marketed and have requested that FDA withdraw approval of the applications. The applicants have also, by their request, waived their opportunity for a hearing. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <TABLE>  <!-- PJG tableformat 3,L1,nj,i1,20C,r40,r40  -->  <!-- PJG 0012 frnewline -->  <!-- PJG 007 0150 intable --> 1ANDA No. <!-- PJG 007 0150 intable --> 1Drug <!-- PJG 007 0150 intable --> 1Applicant <!-- PJG 007 0152 intable -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=01 g=1 f=1 --> 70&hyph;106 <!-- PJG 007 0104 intable --> Metoclopramide Tablets, U.S.P., 10 milligrams (mg) <!-- PJG 007 0104 intable --> King Pharmaceuticals, Inc., 501 Fifth St., Bristol, TN 37620. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 70&hyph;484 <!-- PJG 007 0104 intable --> Betamethasone Valerate Lotion, U.S.P., 0.1%  <!-- PJG 007 0104 intable --> Pharmafair, Inc., 110 Kennedy Dr., Hauppauge, NY 11788. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 72&hyph;817 <!-- PJG 007 0104 intable --> Albuterol Tablets, U.S.P., 2 mg <!-- PJG 007 0104 intable --> Warner Chilcott Laboratories, 201 Tabor Rd., Morris Plains, NJ 07950. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 72&hyph;818 <!-- PJG 007 0104 intable --> Albuterol Tablets, U.S.P., 4 mg  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline --> 80&hyph;635 <!-- PJG 007 0104 intable --> Diphenhydramine Hydrochloride Capsules, U.S.P., 50 mg  <!-- PJG 007 0104 intable --> Roxane Laboratories, Inc., P.O. Box 16532, Colombus, OH 43216&hyph;6532. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 80&hyph;731 <!-- PJG 007 0104 intable --> Cortisone Acetate Tablets, U.S.P., 25 mg  <!-- PJG 007 0104 intable --> Inwood Laboratories, Inc., 300 Prospect St., Inwood, NY 11896. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 80&hyph;732 <!-- PJG 007 0104 intable --> Hydrocortisone Tablets, U.S.P., 20 mg  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 80&hyph;932 <!-- PJG 007 0104 intable --> Propylthiouracil Tablets, U.S.P., 50 mg  <!-- PJG 007 0104 intable --> Danbury Pharmacal, Inc., 131 West St., Danbury, CT 06810. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 85&hyph;902 <!-- PJG 007 0104 intable --> Homatropine Methylbromide Tablets, U.S.P., 10 mg  <!-- PJG 007 0104 intable --> Lemmon Co., 650 Cathill Rd., Sellersville, PA 18960. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 86&hyph;610 <!-- PJG 007 0104 intable --> Amitriptyline Hydrochloride Tablets, U.S.P., 10 mg  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 86&hyph;853  <!-- PJG 007 0104 intable --> Amitriptyline Hydrochloride Tablets, U.S.P., 150 mg  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> 86&hyph;854  <!-- PJG 007 0104 intable --> Amitriptyline Hydrochloride Tablets, U.S.P., 100 mg  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 86&hyph;857  <!-- PJG 007 0104 intable --> Amitriptyline Hydrochloride Tablets, U.S.P., 50 mg  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 86&hyph;859  <!-- PJG 007 0104 intable --> Amitriptyline Hydrochloride Tablets, U.S.P., 25 mg  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> 86&hyph;860  <!-- PJG 007 0104 intable --> Amitriptyline Hydrochloride Tablets, U.S.P., 75 mg  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 87&hyph;838  <!-- PJG 007 0104 intable --> Hydrocortisone Cream, U.S.P., 1%  <!-- PJG 007 0104 intable --> Pharmafair, Inc.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 88&hyph;150  <!-- PJG 007 0104 intable --> Cyclopentolate Hydrochloride Ophthalmic Solution, U.S.P., 1%  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> 88&hyph;274  <!-- PJG 007 0104 intable --> Tropicamide Ophthalmic Solution, U.S.P., 0.5%  <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> 88&hyph;433  <!-- PJG 007 0104 intable --> Dexamethasone Sodium Phosphate Ophthalmic, Solution, U.S.P., 0.1% <!-- PJG 0012 frnewline -->   <!-- PJG 007 0104 intable --> Do. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> 88&hyph;560  <!-- PJG 007 0104 intable --> Hydralazine Hydrochloride Tablets, U.S.P.  <!-- PJG 007 0104 intable --> Amide Pharmaceutical, Inc., 101 East Main St., Little Falls, NJ 07424. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 88&hyph;643 <!-- PJG 007 0104 intable --> Cyclopentolate Hydrochloride Ophthalmic Solution, U.S.P., 0.5%  <!-- PJG 007 0104 intable --> Pharmafair, Inc. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> 88&hyph;649 <!-- PJG 007 0104 intable --> Hydralazine Hydrochloride Tablets, U.S.P.  <!-- PJG 007 0104 intable --> Amide Pharmaceutical, Inc. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> 88&hyph;713 <!-- PJG 007 0104 intable --> Hydroxyzine Pamoate Capsules, U.S.P., 25 mg <!-- PJG 0012 frnewline -->  <!-- PJG 007 0104 intable --> Lemmon Co. <!-- PJG 0012 frnewline -->   <!-- PJG 0012 frnewline --> 88&hyph;746 <!-- PJG 007 0104 intable --> Theophylline Syrup, 150 mg/15 milliliters <!-- PJG 007 0104 intable --> Marion Merrell Dow, Inc., P.O. Box 9627, Kansas City, MO 64134&hyph;0627. <!-- PJG 0012 frnewline --> 88&hyph;947 <!-- PJG 007 0104 intable --> Sulfacetamide Sodium 10% with Hydroxyethylcellulose Ophthalmic Solution  <!-- PJG 007 0104 intable --> Pharmafair, Inc. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 89&hyph;115 <!-- PJG 007 0104 intable --> Butalbital, Acetaminophen, and Caffeine Capsules, U.S.P., 50 mg/325 mg/40 mg  <!-- PJG 007 0104 intable --> Krebs and Associates, P.C., For U.S. Pharmaceutical Corp., 2401&hyph;C Mellon Ct., Decatur, GA 30035. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> 89&hyph;360 <!-- PJG 007 0104 intable --> Hydrocodone Bitartrate and Acetaminophen Capsules, U.S.P., 5 mg/500 mg  <!-- PJG 007 0104 intable --> Central Pharmaceuticals, Inc., 120 East Third St., P.O. Box 328, Seymour, IN 47274&hyph;0328. <!-- PJG /ITAG -->  </TABLE>  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> Therefore, under section 505(e) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(e)) and under authority delegated to the Director, Center for Drug Evaluation and Research (21 CFR 5.82), approval of the ANDA's listed above, and all amendments and supplements thereto, is hereby withdrawn, effective November 18, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: October 4, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SUPPLEM> <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Janet Woodcock,  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Director, Center for Drug Evaluation and Research. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;25909 Filed 10&hyph;18&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;01&hyph;F <!-- PJG /ITAG --> </BILLING>  <!-- PJG /STAG --></p>
		</main>
</body></html>
            